Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ALLOGENEIC TRANSPLANTATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 659 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alyea, EP; Anderson, KC
      Allotransplantation for multiple myeloma

      CANCER JOURNAL
    2. Singh, N
      Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays

      LIVER TRANSPLANTATION
    3. Kyle, RA
      Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy

      CLINICAL LYMPHOMA
    4. Gurman, G; Dilek, I; Arslan, O; Arat, M; Beksac, M; Ilhan, O; Ozcan, M; Akan, H; Dalva, K; Konuk, N; Uysal, A; Koc, H
      The effect of G-CSF on lymphocyte subsets and CD34+cells in allogeneic stem cell transplantation

      TRANSFUSION AND APHERESIS SCIENCE
    5. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    6. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    7. Bylsma, GW; Hall, AJH; Szer, J; West, R
      Atypical retinal microvasculopathy after bone marrow transplantation

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    8. Gluckman, E; Rocha, V; Chevret, S
      Results of unrelated umbilical cord blood hematopoietic stem cell transplant

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    9. Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D
      Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    10. Akpek, G; Lee, SM; Anders, V; Vogelsang, GB
      A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    11. Klein, AK; Patel, DD; Gooding, ME; Sempowski, GD; Chen, BJ; Liu, CX; Kurtzberg, J; Haynes, BF; Chao, NJ
      T-cell recovery in adults and children following umbilical cord blood transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Stern, JM; Sullivan, KM; Ott, SM; Seidel, K; Fink, JC; Longton, G; Sherrard, DF
      Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    13. Zaucha, JM; Zellmer, E; Georges, G; Little, MT; Storb, R; Storer, B; Torok-Storb, B
      G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    14. Feinstein, L; Storb, R
      Reducing transplant toxicity

      CURRENT OPINION IN HEMATOLOGY
    15. Gutierrez-Delgado, F; Bensinger, W
      Safety of granulocyte colony-stimulating factor in normal donors

      CURRENT OPINION IN HEMATOLOGY
    16. Singh, N
      Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients

      CLINICAL INFECTIOUS DISEASES
    17. Fujii, S; Shimizu, K; Fujimoto, K; Kiyokawa, T; Tsukamoto, A; Sanada, I; Kawano, F
      Treatment of post-transplanted, relapsed patients with hematological malignancies by infusion of HLA-matched, allogeneic-dendritic cells (DCs) pulsedwith irradiated tumor cells and primed T cells

      LEUKEMIA & LYMPHOMA
    18. Boiron, JM; Lerner, D; Pigneux, A; Faberes, C; Bordessoule, D; Turlure, P; Cony-Makhoul, P; Hau, F; Dazey, B; Agape, P; Reiffers, J; Marit, G
      Allogeneic transplantation for patients with advanced acute leukemia: a single center retrospective study of 92 patients

      LEUKEMIA & LYMPHOMA
    19. Smith, BD; Moliterno, AR
      Biology and management of idiopathic myelofibrosis

      CURRENT OPINION IN ONCOLOGY
    20. Childs, RW
      Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma

      CRITICAL REVIEWS IN IMMUNOLOGY
    21. Hsu, PN; Lin, HH; Tu, CF; Chen, NJ; Wu, KM; Tsai, HF; Hsieh, SL
      Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts

      JOURNAL OF BIOMEDICAL SCIENCE
    22. Verbeek, W; Ganser, A
      Evolving treatment options of myelodysplastic syndromes

      ANNALS OF HEMATOLOGY
    23. Chen, YC; Ho, CL; Kao, WY; Hwang, JM; Sheu, LF; Chao, TY
      Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients

      ANNALS OF HEMATOLOGY
    24. Kanamori, H; Mishima, A; Tanaka, M; Yamaji, S; Fujisawa, S; Koharazawa, H; Nishikawa, M; Matsuzaki, M; Mohri, H; Ishigatsubo, Y
      Bronchiolitis obliterans organizing pneumonia (BOOP) with suspected liver graft-versus-host disease after allogeneic bone marrow transplantation

      TRANSPLANT INTERNATIONAL
    25. Ohta, H; Kim, JY; Sawada, A; Tokimasa, S; Fujisaki, H; Matsuda, Y; Osugi, Y; Hara, J
      Second transplantation with CD34(+) blood cells from an HLA-mismatched related donor after engraftment failure of transplanted cord blood cells

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    26. Trullemans, F; Grignard, F; Van Camp, B; Schots, R
      Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    27. Garderet, L; Bittencourt, H; Kaliski, A; Daniel, MT; Ribaud, P; Socie, G; Gluckman, E
      Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    28. Jenke, A; Renner, U; Richter, M; Freiberg-Richter, J; Platzbecker, U; Helwig, A; Thiede, HM; Schafer-Eckart, K; Ehninger, G; Bornhauser, M
      Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

      CLINICAL TRANSPLANTATION
    29. Schaap, N; Schattenberg, A; Bar, B; Preijers, F; van Kemenade, EV; de Witte, T
      Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donorleukocyte infusions

      LEUKEMIA
    30. Garban, F; Attal, M; Rossi, JF; Payen, C; Fegueux, N; Sotto, JJ
      Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation

      LEUKEMIA
    31. Massenkeil, G; Fiene, C; Rosen, O; Michael, R; Reisinger, W; Arnold, R
      Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis

      LEUKEMIA
    32. Witherspoon, RP; Deeg, HJ; Storer, B; Anasetti, C; Storb, R; Appelbaum, FR
      Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia

      JOURNAL OF CLINICAL ONCOLOGY
    33. Karrer, S; Holler, E; Szeimies, RM
      Cutaneous manifestations of graft-versus-host disease

      MEDIZINISCHE KLINIK
    34. Lee, KH; Lee, JH; Lee, JH; Kim, WK; Chi, HS; Lee, JS
      Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation

      HAEMATOLOGICA
    35. di Grazia, C; Raiola, AM; Van Lint, MT; Lamparelli, T; Gualandi, F; Berisso, G; Bregante, S; Dominietto, A; Mordini, N; Bruno, B; Frassoni, F; Bacigalupo, A
      Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft

      HAEMATOLOGICA
    36. Dotti, G; Gaspari, F; Caruso, R; Perico, N; Remuzzi, G; Barbui, T; Rambaldi, A
      Pharmacokinetic study of the new cyclosporin-A formulation (Neoral (TM)) in adult allogeneic bone marrow transplant recipients

      HAEMATOLOGICA
    37. Sautois, B; Baudoux, E; Salmon, JP; Michaux, S; Schaaf-Lafontaine, N; Pereira, M; Paulus, JM; Fillet, G; Beguin, Y
      Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation

      HAEMATOLOGICA
    38. Matsubara, H; Makimoto, A; Takayama, J; Higa, T; Saito, T; Kanda, Y; Tanosaki, R; Mineishi, S; Ohira, M; Takaue, Y
      Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    39. Iwasaki, N; Gohda, T; Itoga, H; Minami, A; Kaneda, K
      Effects of major histocompatibility complex matching on graft survival in allogeneic rat limb transplantation

      JOURNAL OF HAND SURGERY-AMERICAN VOLUME
    40. Bibawi, S; Abi-Said, D; Fayad, L; Anderlini, P; Ueno, NT; Mehra, R; Khouri, I; Giralt, S; Gajewski, J; Donato, M; Claxton, D; Braunschweig, I; van Besien, K; Andreeff, M; Andersson, BS; Estey, EH; Champlin, R; Przepiorka, D
      Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    41. Tayebi, H; Kuttler, F; Saaa, P; Lienard, A; Petracca, B; Lapierre, V; Ferrand, C; Fest, T; Cahn, JY; Blaise, D; Kuentz, M; Herve, P; Tiberghien, P; Robinet, E
      Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells

      EXPERIMENTAL HEMATOLOGY
    42. Rocha, V; Carmagnat, MV; Chevret, S; Flinois, O; Bittencourt, H; Esperou, H; Garnier, F; Ribaud, P; Devergie, A; Socie, G; Dal'Cortivo, L; Marolleau, JP; Charron, D; Gluckman, E; Rabian, C
      Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

      EXPERIMENTAL HEMATOLOGY
    43. Sweetenham, JW
      Stem cell transplantation for mantle cell lymphoma: should it ever be usedoutside clinical trials?

      BONE MARROW TRANSPLANTATION
    44. Chakraverty, R; Robinson, S; Peggs, K; Kottaridis, PD; Watts, MJ; Ings, S; Hale, G; Waldmann, H; Linch, DC; Goldstone, AH; Mackinnon, S
      Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    45. Le Blanc, R; Montminy-Metivier, S; Belanger, R; Busque, L; Fish, D; Roy, DC; Kassis, J; Boileau, J; Lavallee, R; Belanger, D; Letendre, F; Hebert, J; Sauvageau, G; Perreault, C; Roy, J
      Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect

      BONE MARROW TRANSPLANTATION
    46. Cornely, OA; Pels, H; Bethe, U; Seibold, M; Toepelt, K; Soehngen, D; Ritzkowsky, A
      A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    47. Oyama, Y; Papadopoulos, EB; Miranda, M; Traynor, AE; Burt, RK
      Allogeneic stem cell transplantation for Evans syndrome

      BONE MARROW TRANSPLANTATION
    48. Vesole, DH; Simic, A; Lazarus, HM
      Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts

      BONE MARROW TRANSPLANTATION
    49. Jacobson, P; Ng, J; Ratanatharathorn, V; Uberti, J; Brundage, RC
      Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients

      BONE MARROW TRANSPLANTATION
    50. Kroger, N; Schetelig, J; Zabelina, T; Kruger, W; Renges, H; Stute, N; Schrum, J; Kabisch, H; Siegert, W; Zander, AR
      A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome

      BONE MARROW TRANSPLANTATION
    51. Maury, S; Belhadj, K; Chami, I; Kuentz, M; Cordonnier, C; Bories, D
      Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population

      BONE MARROW TRANSPLANTATION
    52. Wassmann, B; Klein, SA; Scheuring, U; Pfeifer, H; Martin, H; Gschaidmeier, H; Hoelzer, D; Ottmann, OG
      Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    53. Benito, AI; Gonzalez-Vicent, M; Garcia, F; Balas, A; Quintero, V; Madero, L; Vicario, JL; Diaz, MA
      Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study

      BONE MARROW TRANSPLANTATION
    54. Devine, SM; Sanborn, R; Jessop, E; Stock, W; Huml, M; Peace, D; Wickrema, A; Yassine, M; Amin, K; Thomason, D; Chen, YH; Devine, H; Maningo, M; van Besien, K
      Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem celltransplant

      BONE MARROW TRANSPLANTATION
    55. Heinonen, H; Volin, L; Uutela, A; Zevon, M; Barrick, C; Ruutu, T
      Gender-associated differences in the quality of life after allogeneic BMT

      BONE MARROW TRANSPLANTATION
    56. Mohty, M; Fegueux, N; Exbrayat, C; Lu, ZY; Legouffe, E; Quittet, P; Lopez-Martinez, E; Latry, P; Avinens, O; Hertog, C; Klein, B; Eliaou, JF; Rossi, JF
      Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy

      BONE MARROW TRANSPLANTATION
    57. Urbano-Ispizua, A; Brunet, S; Solano, C; Moraleda, JM; Rovira, M; Zuazu, J; de la Rubia, J; Bargay, J; Caballero, D; Diez-Martin, JL; Ojeda, E; de Oteiza, JP; Ferra, C; Espigado, I; Alegre, A; de la Serna, J; Torres, P; Riu, C; Odriozola, J; Rozman, C; Sierra, J; Garcia-Conde, J; Montserrat, E
      Allogeneic transplantation of CD34(+)-selected cells from peripheral bloodin patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

      BONE MARROW TRANSPLANTATION
    58. Gandini, A; Roata, C; Franchini, M; Agostini, E; Guizzardi, E; Giacometti, PP; Vassanelli, A; Rocca, P; Zanuso, C; Fasolo, R; de Gironcoli, M; Gandini, G; Benedetti, F; Aprili, G
      Unrelated allogeneic bone marrow donation: short- and long-term follow-up of 103 consecutive volunteer donors

      BONE MARROW TRANSPLANTATION
    59. Morecki, S; Gelfand, Y; Nagler, A; Or, R; Naparstek, E; Varadi, G; Engelhard, D; Akerstein, A; Slavin, S
      Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

      BONE MARROW TRANSPLANTATION
    60. Ratanatharathorn, V; Ayash, L; Lazarus, HM; Fu, J; Uberti, JP
      Chronic graft-versus-host disease: clinical manifestation and therapy

      BONE MARROW TRANSPLANTATION
    61. Kreiter, S; Winkelmann, N; Schneider, PM; Schuler, M; Fischer, T; Ullmann, AJ; Huber, C; Derigs, HG; Kolbe, K
      Failure of sustained engraftment after non-myeloablative conditioning withlow-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation

      BONE MARROW TRANSPLANTATION
    62. Ferra, C; Rodriguez-Luaces, M; Gallardo, D; Encuentra, M; Martin-Henao, GA; Peris, J; Ancin, I; Serra, J; Berlangal, JJ; Garcia, J; Granena, A
      Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    63. Nivison-Smith, I; Bradstock, KF; Szer, J; Durrant, S; Dodds, A; Hermann, R; Schwarer, AP; Gibson, J; To, LB; Arthur, C
      Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow

      BONE MARROW TRANSPLANTATION
    64. Ancin, I; Ferra, C; Gallardo, D; Peris, J; Berlanga, J; Gonzalez, JR; Virgili, N; Granena, A
      Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?

      BONE MARROW TRANSPLANTATION
    65. Runde, V; Ross, S; Trenschel, R; Lagemann, E; Basu, O; Renzing-Kohler, K; Schaefer, UW; Roggendorf, M; Holler, E
      Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study

      BONE MARROW TRANSPLANTATION
    66. Moscardo, F; Sanz, GF; de la Rubia, J; Jimenez, C; Saavedra, S; Regadera, A; Andreu, R; Garcia, I; Plume, G; Martinez, J; Martin, G; Jarque, I; Sanz, MA
      Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection

      BONE MARROW TRANSPLANTATION
    67. Fujii, N; Takenaka, K; Shinagawa, K; Ikeda, K; Maeda, Y; Sunami, K; Hiramatsu, Y; Matsuo, K; Ishimaru, F; Niiya, K; Yoshino, T; Hirabayashi, N; Harada, M
      Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    68. Reynolds, C; Ratanatharathorn, V; Adams, P; Braun, T; Silver, S; Ayash, L; Carson, E; Eisbruch, A; Dawson, LA; McDonagh, K; Ferrara, J; Uberti, J
      Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

      BONE MARROW TRANSPLANTATION
    69. Minegishi, M; Ohashi, Y; Kumaki, S; Sasahara, Y; Hayashi, T; Asada, H; Okuyama, T; Hakozaki, I; Sato, T; Tsuchiya, S
      Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

      BONE MARROW TRANSPLANTATION
    70. Anderlini, P; Rizzo, JD; Nugent, ML; Schmitz, N; Champlin, RE; Horowitz, MM
      Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

      BONE MARROW TRANSPLANTATION
    71. Leung, W; Pitts, N; Burnette, K; Cunningham, JM; Horwitz, EM; Benaim, E; Hale, G; Woodard, P; Pui, CH; Bowman, LC
      Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome

      BONE MARROW TRANSPLANTATION
    72. Hirokawa, M; Matsutani, T; Horiuchi, T; Kawabata, Y; Kitabayashi, A; Yoshioka, T; Tsuruta, Y; Suzuki, R; Miura, AB
      Extensive clonal expansion of T lymphocytes causes contracted diversity ofcomplementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation

      BONE MARROW TRANSPLANTATION
    73. Ozcan, M; Ustun, C; Akcaglayan, E; Akan, H; Arslan, O; Ilhan, O; Beksac, M; Gurman, G; Demirer, T; Arat, M; Celebi, H; Konuk, N; Uysal, A; Koc, H
      Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    74. Platzbecker, U; Thiede, C; Freiberg-Richter, J; Rollig, C; Helwig, A; Schakel, U; Mohr, B; Schaich, M; Ehninger, G; Bornhauser, M
      Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    75. Koc, ON; Lazarus, HM
      Mesenchymal stem cells: heading into the clinic

      BONE MARROW TRANSPLANTATION
    76. Chan, KW; Li, CK; Worth, LL; Chik, KW; Jeha, S; Shing, MK; Yuen, PM
      A fludarabine-based conditioning regimen for severe aplastic anemia

      BONE MARROW TRANSPLANTATION
    77. Yamada, S; Takatsuka, H; Takemoto, Y; Wada, H; Fujimori, Y; Okamoto, T; Kanamaru, A; Kakishita, E
      Urinary trypsin inhibitor concentration can predict the immunological insult of chemotherapy and complications after bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    78. Hattori, K; Yabe, M; Matsumoto, M; Kudo, Y; Yasuda, Y; Inoue, H; Minami, S; Miyakita, H; Kawamura, N; Komori, K; Yamamoto, I; Yabe, H
      Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    79. Kumar, S; Chen, MG; Gastineau, DA; Gertz, MA; Inwards, DJ; Lacy, MQ; Tefferi, A; Harmsen, WS; Litzow, MR
      Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease

      BONE MARROW TRANSPLANTATION
    80. Omazic, B; Nasman-Bjork, I; Johansson, J; Hentschke, P; Mattsson, J; Permert, J; Lundkvist, I
      Altered expression of receptors for thyroid hormone and insulin-like growth factor-1 during reconstitution after allogeneic hematopoietic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    81. Siston, AK; List, MA; Daugherty, CK; Banik, DM; Menke, C; Cornetta, K; Larson, RA
      Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    82. Anagnostopoulos, A; Dimopoulos, MA; Aleman, A; Weber, D; Alexanian, R; Champlin, R; Giralt, S
      High-dose chemotherapy - High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia

      BONE MARROW TRANSPLANTATION
    83. Barge, RMY; Brouwer, RE; Beersma, MFC; Starrenburg, CWJ; Zwinderman, AH; Hale, G; Waldmann, H; den Ottolander, GJ; Falkenburg, JHF; Willemze, R; Fibbe, WE
      Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome

      BONE MARROW TRANSPLANTATION
    84. Laughlin, MJ
      Umbilical cord blood for allogeneic transplantation in children and adults

      BONE MARROW TRANSPLANTATION
    85. Regn, S; Raffegerst, S; Chen, X; Schendel, D; Kolb, HJ; Roskrow, M
      Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant

      BONE MARROW TRANSPLANTATION
    86. Champlin, R; Khouri, I; Anderlini, P; Gajewski, J; Kornblau, S; Molldrem, J; Shimoni, A; Ueno, N; Giralt, S
      Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation

      BONE MARROW TRANSPLANTATION
    87. Weaver, CH; Schulman, KA; Buckner, CD
      Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

      BONE MARROW TRANSPLANTATION
    88. Lin, J; Markowtiz, GS; Nicolaides, M; Hesdorffer, CS; Appel, GB; D'Agati, VD; Savage, DG
      Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation - Report of 2 cases and review of the literature

      AMERICAN JOURNAL OF NEPHROLOGY
    89. Benoist, S; Sarkis, R; Chafai, N; Barbu, W; Honiger, J; Lakehal, F; Becquemont, L; Baudrimont, M; Capeau, J; Housset, C; Nordlinger, B
      Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression

      JOURNAL OF HEPATOLOGY
    90. Leda, M; Ladon, D; Pieczonka, A; Boruczkowski, D; Jolkowska, J; Witt, M; Wachowiak, J
      Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

      LEUKEMIA RESEARCH
    91. Hui, CH; Bardy, P; Hughes, T; Horvath, N; To, LB
      Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases

      CLINICAL AND LABORATORY HAEMATOLOGY
    92. Wagner, T; Fritsch, G; Thalhammer, R; Hocker, P; Lanzer, G; Lechner, K; Geissler, K
      IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+cells

      TRANSFUSION
    93. de la Rubia, J; Diaz, MA; Verdeguer, A; Pascual, MJ; Arbona, C; Arrieta, R; Brunet, S; Bargay, J; Martinez, C; Espigado, I; Serrano, D; Alegre, A; de Arriba, F; de la Serna, J; Zamora, C; Benlloch, L; Sanz, MA
      Donor age-related differences in PBPC mobilization with rHuG-CSF

      TRANSFUSION
    94. Bjorkstrand, B
      European group for blood and marrow transplantation registry studies in multiple myeloma

      SEMINARS IN HEMATOLOGY
    95. Fassas, A; Tricot, G
      Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma

      SEMINARS IN HEMATOLOGY
    96. Nakayama, T; Kudo, H; Suzuki, S; Sassa, S; Mano, Y; Sakamoto, S
      Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats

      LIFE SCIENCES
    97. Kern, A; Liu, K; Mansbridge, J
      Modification of fibroblast gamma-interferon responses by extracellular matrix

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    98. Choi, EY; Yoshimura, Y; Christianson, GJ; Sproule, TJ; Malarkannan, S; Shastri, N; Joyce, S; Roopenian, DC
      Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over allothers

      JOURNAL OF IMMUNOLOGY
    99. Mattsson, J; Uzunel, M; Remberger, M; Tammik, L; Omazic, B; Levitsky, V; Zou, JZ; Hentschke, P; Ringden, O
      Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    100. Cao, TM; Kusnierz-Glaz, C; Valone, F; Stockerl-Goldstein, KE; Hu, WW; Johnston, L; Blume, KG; Strober, S; Negrin, RS
      Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies

      CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 11:38:44